Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in localized GIST after surgery
NCT02009423Phase 3Terminated
- Sponsor
- AB Science
- Start
- Jul 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of masitinib in gastrointestinal stromal tumor (GIST), sponsored by AB Science. Started Jul 2015; status: terminated.
02
Drugs
masitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT02009423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02009423.